YU43931B - Process for making derivatives of imidazolidin-dione - Google Patents

Process for making derivatives of imidazolidin-dione

Info

Publication number
YU43931B
YU43931B YU897/84A YU89784A YU43931B YU 43931 B YU43931 B YU 43931B YU 897/84 A YU897/84 A YU 897/84A YU 89784 A YU89784 A YU 89784A YU 43931 B YU43931 B YU 43931B
Authority
YU
Yugoslavia
Prior art keywords
spiro
trione
imidazolidine
indoline
imidazolidin
Prior art date
Application number
YU897/84A
Other languages
English (en)
Other versions
YU89784A (en
Inventor
A Jeffrey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU89784A publication Critical patent/YU89784A/xx
Publication of YU43931B publication Critical patent/YU43931B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • External Artificial Organs (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
YU897/84A 1983-05-25 1984-05-23 Process for making derivatives of imidazolidin-dione YU43931B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
YU89784A YU89784A (en) 1987-04-30
YU43931B true YU43931B (en) 1989-12-31

Family

ID=23979057

Family Applications (2)

Application Number Title Priority Date Filing Date
YU897/84A YU43931B (en) 1983-05-25 1984-05-23 Process for making derivatives of imidazolidin-dione
YU2122/86A YU43958B (en) 1983-05-25 1986-12-11 Process for obtaining derivatives of imidazolydindione

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU2122/86A YU43958B (en) 1983-05-25 1986-12-11 Process for obtaining derivatives of imidazolydindione

Country Status (19)

Country Link
US (1) US4464380A (ru)
EP (1) EP0127412B1 (ru)
JP (1) JPS604183A (ru)
KR (1) KR860001869B1 (ru)
AT (1) ATE57531T1 (ru)
AU (1) AU543916B2 (ru)
CA (1) CA1266270A (ru)
DE (1) DE3483402D1 (ru)
DK (1) DK163924C (ru)
ES (2) ES532736A0 (ru)
FI (1) FI78699C (ru)
GR (1) GR82020B (ru)
HU (1) HU190548B (ru)
IE (1) IE57520B1 (ru)
IL (1) IL71904A (ru)
PH (1) PH21151A (ru)
PL (3) PL252850A1 (ru)
PT (1) PT78625A (ru)
YU (2) YU43931B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172719B1 (en) * 1984-08-20 1988-09-21 Pfizer Inc. Process for the production as asymmetric hydantoins
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
EP0769497B1 (de) * 1995-10-18 2002-12-18 F. Hoffmann-La Roche Ag Hydroxymethylierung von Tocopherolen
JP4601175B2 (ja) 1998-12-19 2010-12-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗ヒスタミン性スピロ化合物
JP2009526044A (ja) * 2006-02-07 2009-07-16 アストラゼネカ・アクチエボラーグ 新規な化合物ｉ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
ES8600764A1 (es) 1985-10-16
DE3483402D1 (de) 1990-11-22
DK250084A (da) 1984-11-26
YU89784A (en) 1987-04-30
EP0127412A3 (en) 1987-09-02
FI842079A0 (fi) 1984-05-24
KR860001869B1 (ko) 1986-10-24
IL71904A (en) 1988-01-31
IL71904A0 (en) 1984-09-30
ES540858A0 (es) 1986-06-01
AU543916B2 (en) 1985-05-09
HUT34194A (en) 1985-02-28
FI78699C (fi) 1989-09-11
JPH0573754B2 (ru) 1993-10-15
AU2856384A (en) 1984-11-29
DK250084D0 (da) 1984-05-22
YU212286A (en) 1987-10-31
ATE57531T1 (de) 1990-11-15
JPS604183A (ja) 1985-01-10
ES8607304A1 (es) 1986-06-01
DK163924C (da) 1992-09-14
PT78625A (en) 1984-06-01
EP0127412A2 (en) 1984-12-05
PL252850A1 (en) 1985-11-19
FI842079A (fi) 1984-11-26
IE841294L (en) 1984-11-25
PL143290B1 (en) 1988-02-29
DK163924B (da) 1992-04-21
EP0127412B1 (en) 1990-10-17
US4464380A (en) 1984-08-07
IE57520B1 (en) 1993-05-19
PH21151A (en) 1987-07-30
HU190548B (en) 1986-09-29
YU43958B (en) 1989-12-31
CA1266270A (en) 1990-02-27
FI78699B (fi) 1989-05-31
PL143070B1 (en) 1988-01-30
PL247804A1 (en) 1985-08-13
ES532736A0 (es) 1985-10-16
GR82020B (ru) 1984-12-12
KR840009101A (ko) 1984-12-24

Similar Documents

Publication Publication Date Title
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
IE790088L (en) Thienohydantoin derivatives
HU907025D0 (en) Process for producing substituted n-(imidazolyl-alkyl)-alanine derivatives and pharmaceutical preparatives containing these compounds as active substance
PT77370A (en) Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same
YU43931B (en) Process for making derivatives of imidazolidin-dione
IE851155L (en) Benzo-(pyrano and thiopyrano)-pyridines
ES8400116A1 (es) "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
ES8103090A1 (es) Un procedimiento para la preparacion de espiro-quinolilludantoinas, utiles como inhibidores de la aldosa-reductasa para el tratamiento de las complicaciones cronicas de la diabetes
MY103765A (en) Azolidinedione derivatives
ES8105711A1 (es) Un metodo de preparar derivados de piperidina
IE800672L (en) Spiro-quinolone hydantoins
ES8607312A1 (es) Un procedimiento para la preparacion de un compuesto seleccionado entre el grupo formado por los isomeros dextrogiros de espiro-hidantoinas asimetricas
PT85378A (en) Process for the preparation of new tetracyclic indole derivatives and of pharmaceutical compositions containing the same
HUT44769A (en) Process for producing spiro/benzofuran-2(3h),1'-cycloheptane/ derivatives and pharmaceutical preparations comprising these compounds
ES8407050A1 (es) Un derivado de trifluormetil-espiro(imidazolidina-4,3'-indolina)-2,2'5-triona.
MX9605604A (es) Nuevos compuestos agonistas.